ACCESSION: MSBNK-SMB_Measured-HSA014P0248005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'EL22-neg_9762': {'bp': 213347.0, 'sum': 943707.0}, 'EL06-neg_9749': {'bp': 137832.0, 'sum': 707310.0}, 'EL05-neg_9700': {'bp': 169799.0, 'sum': 827264.0}, 'EL19-neg_9763': {'bp': 147939.0, 'sum': 722279.0}, 'EL09-neg_9722': {'bp': 128129.0, 'sum': 634322.0}, 'EL11-neg_9090': {'bp': 91509.0, 'sum': 462904.0}, 'EL10-neg_9650': {'bp': 111721.0, 'sum': 557948.0}, 'EL10-neg_9716': {'bp': 94049.0, 'sum': 437868.0}, 'EL16-neg_9712': {'bp': 105675.0, 'sum': 521196.0}, 'EL23-neg_9108': {'bp': 106191.0, 'sum': 509764.0}, 'EL01-neg_9095': {'bp': 94307.0, 'sum': 448373.0}, 'Blanc3-neg_9670': {'bp': 79707.0, 'sum': 391330.0}, 'EL13-neg_9711': {'bp': 106389.0, 'sum': 549525.0}, 'EL18-neg_9722': {'bp': 91032.0, 'sum': 435761.0}, 'EL02-neg_9784': {'bp': 170939.0, 'sum': 829752.0}}
COMMENT: RETENTION_TIME_STDEV 0.430
COMMENT: PRECURSOR_M/Z_RAW 248.079856
COMMENT: PRECURSOR_M/Z_STDEV 0.000103
COMMENT: PRECURSOR_IN_MS1 mz 248.080071; int 100.518; delta(ppm) 1.018917
COMMENT: PROPOSED_CHARGE_STATE -2; mz 248.581662; int 28.014; cor 0.839
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 2.015; C8H16N3O4P; [M-H]1; delta(ppm) -2.015357
COMMENT: PROPOSED_MF SevenGoldenRules 4.617; C10H11N5O3; [M-H]1; delta(ppm) 4.616854
COMMENT: PROPOSED_MF MS-FINDER 2.575; C10H11N5O3; [M-H]-; delta(ppm) 4.636339
COMMENT: PROPOSED_MF MS-FINDER 2.204; C8H16N3O4P; [M-H]-; delta(ppm) -2.021878
COMMENT: PROPOSED_MF MS-FINDER 1.898; C6H19NO7S; [M-H]-; delta(ppm) -3.561481
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.691; C10H11N5O3; [M-H]-; delta(ppm) 4.636339
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.360; C9H16ClN3O3; [M-H]-; delta(ppm) -88211.608455
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.104; C10H19NO2S2; [M-H]-; delta(ppm) 6.524446
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.134; C8H16N3O4P; [M-H]-; delta(ppm) -2.021878
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.247; C10H11F4N3; [M-H]-; delta(ppm) -6.328325
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.402; C7H15N5O3S; [M-H]-; delta(ppm) -8.952472
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.080; C7H15ClF3N3O; [M-H]-; delta(ppm) -88203.413850
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.246; C12H13N2O4; [M-H]-; delta(ppm) -0.775901
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.833; C4H12N9O2P; [M-H]-; delta(ppm) 8.802633
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.222; C13H9N6; [M-H]-; delta(ppm) -6.166921
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H11N5O3; [M-H]-; delta(ppm) 4.636339
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.319; MBVGIEDXZGVICG-FXZMZVCPSA-N; [M-H]-; NC1=NC=NC2=C1N=C1[C@@H](O)[C@H]3O[C@H](C[C@@H]3O)N21
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.268; HTCCXYNTBWNVOY-UHFFFAOYSA-M; [M-H]-; O=C([O-])[C]1[CH][NH2+][C]2[C](OC)[CH][CH][C](OC)[C]2[C]1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.261; MJBHZZFNUSRWLB-UHFFFAOYSA-N; [M-H]-; O=C1N=C2C(N=CN2C(=O)C)=C(NC(=O)C)N1C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.261; AJJUTOVQGXWTBW-UHFFFAOYSA-M; [M-H]-; O=C([O-])[C]1[CH][NH2+][C]2[CH][C](OC)[C](OC)[CH][C]2[C]1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.238; FZYYPNOHKXTKLI-NTSWFWBYSA-N; [M-H]-; C1=CC(OC1CO)N2C=NC3=C2N=C(NC3=O)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.148; MBVGIEDXZGVICG-FXZMZVCPSA-N; [M-H]-; 8,5'-cyclo-2'-deoxyadenosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.096; FZYYPNOHKXTKLI-NTSWFWBYSA-N; [M-H]-; 2-amino-9-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.096; MVLWYDGJBGPXOL-UHFFFAOYSA-N; [M-H]-; 4-nitro-7-piperazin-1-yl-2,1,3-benzoxadiazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.096; MJBHZZFNUSRWLB-UHFFFAOYSA-N; [M-H]-; CNP0438358
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MBVGIEDXZGVICG-FXZMZVCPSA-N; [M-H]-; 8,5'-cyclo-2'-deoxyadenosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FZYYPNOHKXTKLI-NTSWFWBYSA-N; [M-H]-; 2-amino-9-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MVLWYDGJBGPXOL-UHFFFAOYSA-N; [M-H]-; 4-nitro-7-piperazin-1-yl-2,1,3-benzoxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; MJBHZZFNUSRWLB-UHFFFAOYSA-N; [M-H]-; CNP0438358
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.333; FZYYPNOHKXTKLI-NTSWFWBYSA-N; [M-H]-; 2-amino-9-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; LUCROQXUUQXLTD-XGICHPGQSA-N; [M-H]-; 5-hydroxy-6-methyl-4-[(Z)-(6-oxo-1H-pyridin-3-yl)methylideneamino]-2,5-dihydro-1,2,4-triazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; MVLWYDGJBGPXOL-UHFFFAOYSA-N; [M-H]-; 4-nitro-7-piperazin-1-yl-2,1,3-benzoxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.373; QSDDQXROWUJAJX-ZCFIWIBFSA-N; [M-H]-; (3R)-1-(4-nitro-2,1,3-benzoxadiazol-7-yl)pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.333; QHGGPFXOKMOHAN-UHFFFAOYSA-N; [M-H]-; 2-(6-nitrobenzimidazol-1-yl)ethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.344; MJBHZZFNUSRWLB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.741; FZYYPNOHKXTKLI; [M-H]-; 2-amino-9-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.437; MBVGIEDXZGVICG; [M-H]-; Cycloda
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.069; RANSNKOSWWZYEJ; [M-H]-; [(1R,2R,4R)-4-(6-aminopurin-9-yl)-3,6-dioxabicyclo[3.1.0]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -289.588; DVIOPVDMECJZFF; [M-H]-; (2R)-2-(6-aminopurin-9-yl)-5-methyl-2,3-dihydrofuran-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -385.106; QHGGPFXOKMOHAN; [M-H]-; Urea, 1-(2-(1-benzimidazolyl)ethyl)-6-nitro-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -392.149; AGFLZLZTKJZHRC; [M-H]-; N-hydroxy-4-[(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)diazenyl]benzeneamine oxide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -434.205; LUCROQXUUQXLTD; [M-H]-; 5-Hydroxy-6-methyl-4-[(Z)-(6-oxo-1H-pyridin-3-yl)methylideneamino]-2,5-dihydro-1,2,4-triazin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -460.702; OKIBSPYVEWBOGG; [M-H]-; 5-Ethyl-6-(5-nitrofuran-2-yl)pyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -484.097; QSDDQXROWUJAJX; [M-H]-; 4-Nitro-7-(3-aminopyrrolizino)-2,1,3-benzooxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.132; MJBHZZFNUSRWLB; [M-H]-; nan
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H10N5O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.453
MS$FOCUSED_ION: PRECURSOR_M/Z 248.080063
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-0490000000-c50f9379f5a83278bdfd
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  79.9559017 126.2266 79.955891 1.1006 19.02 0.8357 15 ?
  92.9264751 25.9093 92.926478 1.5389 9.65 0.2636 11 ?
  99.9240910 35.4848 99.924104 1.4611 21.93 -0.8545 11 ?
  112.9841119 37.0257 112.984146 1.3365 11.17 0.3670 14 ?
  176.9929821 88.5960 176.993185 1.1187 11.86 0.9321 15 ?
  184.0007250 955.4820 184.000953 0.5054 58.21 0.9571 15 ?
  184.5026031 190.9671 184.502799 1.1165 17.58 0.9429 15 ?
  191.0092288 47.4048 191.008907 1.2617 9.78 0.6455 11 f{C6H1N5O3}/3.88ppm,p-C4H9
  200.5006804 30.4668 200.500154 1.3466 8.01 0.7890 14 ?
  205.1597199 451.0364 205.159237 0.5069 60.59 0.8893 15 ?
  206.1631960 43.8016 206.162723 1.5037 9.56 0.7622 12 ?
  248.0800051 999.0000 248.080043 0.5603 40.51 1.0000 15 f{C10H10N5O3}/4.40ppm,p
  248.5816532 293.6281 248.581699 0.7161 32.66 0.8643 15 ?
  248.9728929 29.9667 248.972944 1.1327 7.31 0.8042 12 ?
  249.0794663 130.9146 249.079519 1.3971 20.43 0.9451 13 ?
  249.1495608 897.5295 249.149615 0.4857 131.77 0.8929 15 ?
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  79.955902 126.23 126
  92.926475 25.91 25
  99.924091 35.48 35
  112.984112 37.03 37
  176.992982 88.60 88
  184.000725 955.48 955
  184.502603 190.97 190
  191.009229 47.40 47
  200.500680 30.47 30
  205.159720 451.04 451
  206.163196 43.80 43
  248.080005 999.00 999
  248.581653 293.63 293
  248.972893 29.97 29
  249.079466 130.91 130
  249.149561 897.53 897
//
